PredictionOdds

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

COMP360 Psilocybin for Treatment-Resistant Depression

Current odds

-1.0 pts · 24h (leader)
Before Jan 1, 202734%
No66%

Before Jan 1, 2027 probability

28%36%43%Jul 18Jul 21Jul 24
Trade on Kalshi

Related markets